LEUPROLIDE ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Leuprolide Acetate patents expire, and what generic alternatives are available?
Leuprolide Acetate is a drug marketed by Amneal, Eugia Pharma, Genzyme, Meitheal, Rk Pharma, Sandoz, Sun Pharm, and Invagen Pharms. and is included in eight NDAs.
The generic ingredient in LEUPROLIDE ACETATE is leuprolide acetate. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Leuprolide Acetate
A generic version of LEUPROLIDE ACETATE was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
Summary for LEUPROLIDE ACETATE
Recent Clinical Trials for LEUPROLIDE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins Bloomberg School of Public Health | Phase 2 |
Takeda | Phase 4 |
Emory University | Phase 4 |